Tablets are seen in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401498
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401497
A view shows scales for tablets weighing in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401492
A tableting site is seen in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401484
An employee adjusts mixer on granulation site in a production workshop of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401476
A pressure gauge is seen on a mixer on granulation site in a production workshop of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401473
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401471
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401454
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401451
An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401448
A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401431
A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401421
An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401420
Employees work at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401396
A view shows the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401389
An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401386
An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401384
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401381
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401378
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401370
A view shows thermostats at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401363
An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401357
A view shows the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants.29.03.2023#8401343
